Compound 1135
Identifiers
- Canonical SMILES:
COC1(CC(C)C)CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O
- IUPAC name:
N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-methoxy-4-(2-methylpropyl)piperidin-1-yl]benzamide
- InChi:
InChI=1S/C35H47N5O6S2/c1-26(2)24-35(46-5)18-21-39(22-19-35)29-13-11-27(12-14-29)34(41)37-48(44,45)31-15-16-32(33(23-31)40(42)43)36-28(17-20-38(3)4)25-47-30-9-7-6-8-10-30/h6-16,23,26,28,36H,17-22,24-25H2,1-5H3,(H,37,41)/t28-/m1/s1
- InChiKey:
AGGPTAKEWABCFB-MUUNZHRXSA-N
External links
![]() 16109137 |
![]() CHEMBL373577 |
![]() 17266550 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 8.21 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 697.30 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 5.05 | |||
TPSA | 136.80 | |||
RB | 15 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
17256834 | 8a | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.25 | |
17256834 | 8a | B2CL1 Q07817 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.21 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5292 | Navitoclax | DB12340 | |
0.4602 | Venetoclax | DB11581 | |
0.4530 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.4506 | Sulfabenzamide | DB09355 | |
0.4352 | Pipotiazine | DB01621 | |
0.4225 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 | |
0.4206 | 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid | DB02449 | |
0.4049 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4025 | Zafirlukast | DB00549 | |
0.3989 | Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide | DB03031 | |
0.3982 | Repinotan | DB06506 | |
0.3964 | Saccharin | DB12418 | |
0.3962 | Nelfinavir | DB00220 | |
0.3923 | Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide | DB04032 | |
0.3849 | VX-659 | DB15177 |